光伏股普漲 隆基、通威漲約4%
格隆匯4月19日丨光伏股普漲,板塊指數漲1.54%。成分股中,雙良節能、銀星能源和隆基股份漲超4%,通威股份漲近4%,賽伍技術、固德威、南玻A、特變電工、太陽能等均漲超2%。通威股份16日晚發佈電池片調價公吿。與3月25日報價相比:多晶金剛線157電池定價為0.70元/W,上漲0.07元/W;上漲單晶方面,單晶PERC 158.75電池上漲2分,報價0.96元/W;單晶PERC 166電池上漲0.03元,報價0.89元/W;單晶PERC 210電池不變,報價0.91元/W。注:通威股份入選了格隆匯2021年十大核心潛力資產名單。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.